| 臺大學術典藏 |
2021-07-13T06:04:31Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; LEE JIH-HSIANG; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:32Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:32Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao B.-C.; Bai Y.-Y.; LEE JIH-HSIANG; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; LEE JIH-HSIANG; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:34Z |
Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy
|
Liao B.-C.; Lin C.-C.; LEE JIH-HSIANG; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:34Z |
Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors
|
Chang I.-S.; Jiang S.S.; Yang J.C.-H.; Su W.-C.; Chien L.-H.; Hsiao C.-F.; LEE JIH-HSIANG; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; Chen K.-Y.; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; Yang P.-C.; Hsiung C.A. |
| 臺大學術典藏 |
2021-07-13T06:04:35Z |
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations
|
Wu T.; Hsiue E.H.; LEE JIH-HSIANG; Lin C.; Yang J.C. |
| 臺大學術典藏 |
2021-07-13T06:04:35Z |
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer
|
Soh S.X.; Siddiqui F.J.; Allen J.C.; Kim G.W.; Lee J.C.; Yatabe Y.; Soda M.; Mano H.; Soo R.A.; Chin T.-M.; Ebi H.; Yano S.; Matsuo K.; Niu X.; Lu S.; Isobe K.; LEE JIH-HSIANG; Yang J.C.; Zhao M.; Zhou C.; Lee J.-K.; Lee S.-H.; Lee J.Y.; Ahn M.-J.; Tan T.J.; Tan D.S.; Tan E.-H.; Ong S.T.; Lim W.-T. |
| 臺大學術典藏 |
2021-07-13T06:04:35Z |
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
|
Liao B.-C.; Lin C.-C.; LEE JIH-HSIANG; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Profile of the therascreen? EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao B.-C.; LEE JIH-HSIANG; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; LEE JIH-HSIANG; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma
|
Weng M.-T.; Tung T.-H.; LEE JIH-HSIANG; Wei S.-C.; Lin H.-L.; Huang Y.-J.; Wong J.-M.; Luo J.; Sheu J.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer
|
Thomas A.; LEE JIH-HSIANG; Abdullaev Z.; Park K.-S.; Pineda M.; Saidkhodjaeva L.; Miettinen M.; Wang Y.; Pack S.D.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
LEE JIH-HSIANG; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:38Z |
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation
|
Giovannetti E.; Wang Q.; Avan A.; Funel N.; Lagerweij T.; LEE JIH-HSIANG; Caretti V.; Van Der Velde A.; Boggi U.; Wang Y.; Vasile E.; Peters G.J.; Wurdinger T.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:38Z |
The janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo
|
LEE JIH-HSIANG; Park K.-S.; Alberobello A.T.; Kallakury B.; Weng M.-T.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:38Z |
Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancer
|
Chen J.-Q.; LEE JIH-HSIANG; Herrmann M.A.; Park K.-S.; Heldman M.R.; Goldsmith P.K.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:39Z |
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
|
Huang M.-H.; LEE JIH-HSIANG; Chang Y.-J.; Tsai H.-H.; Lin Y.-L.; Lin A.M.Y.; Yang J.C.H. |
| 臺大學術典藏 |
2021-07-13T06:04:39Z |
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells
|
Weng M.-T.; LEE JIH-HSIANG; Wei S.-C.; Li Q.; Shahamatdar S.; Hsu D.; Schetter A.J.; Swatkoski S.; Mannan P.; Garfield S.; Gucek M.; Kim M.K.H.; Annunziata C.M.; Creighton C.J.; Emanuele M.J.; Harris C.C.; Sheu J.-C.; Giaccone G.; Luo J. |
| 臺大學術典藏 |
2021-07-13T06:04:39Z |
Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer
|
LEE JIH-HSIANG; Giovannetti E.; Hwang J.-H.; Petrini I.; Wang Q.; Voortman J.; Wang Y.; Steinberg S.M.; Funel N.; Meltzer P.S.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
MicroRNA expression and clinical outcome of small cell lung cancer
|
LEE JIH-HSIANG; Voortman J.; Dingemans A.-M.C.; Voeller D.M.; Pham T.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; LEE JIH-HSIANG; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors
|
Voortman J.; LEE JIH-HSIANG; Killian J.K.; Suuriniemi M.; Wang Y.; Lucchi M.; Smith Jr. W.I.; Meltzer P.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:41Z |
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer
|
LEE JIH-HSIANG; Yu C.-J.; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H. |
| 臺大學術典藏 |
2021-07-13T07:43:00Z |
Old theory, new application: A novel debriefing framework
|
Liu, Cheng-Heng; Chou, Fremen Chihchen; Hsiao, Cheng-Ting; CHIH-WEI YANG |
| 臺大學術典藏 |
2021-07-13T07:45:08Z |
Barriers to bystanders defibrillation: A national survey on public awareness and willingness of bystanders defibrillation☆
|
Pei-Chuan Huang, Edward; Chiang, Wen-Chu; Lu, Tsung-Chien; Wang, Chih-Hung; Sun, Jen-Tang; Hsieh, Ming-Ju; Wang, Hui-Chih; CHIH-WEI YANG; Lin, Chih-Hao; Lin, Jr-Jiun; Yang, Ming-Chin; Huei-Ming Ma, Matthew |
| 國立臺中教育大學 |
2021-07-14 |
臺灣燈會主燈造形風格意象之探討與創作
|
王士豪; Wang, Shih-Hao |
| 國立臺中教育大學 |
2021-07-14 |
領導力工具對國小六年級學童閱讀理解成效及七個習慣的影響
|
黃于綸; HUANG, YU-LUN |
| 國立臺中教育大學 |
2021-07-14 |
眼動軌跡分析閱覽歷程˗以國立自然科學博物館之教育展版為例
|
姚子健; YAO, TZU-CHIEN |
| 元培科技大學 |
2021-07-14 |
元培茶陶所畢業生手作百件茶碗詮釋故鄉情懷
|
元培醫事科技大學 |
| 國家衛生研究院 |
2021-07-14 |
Associations between antidepressant use and advanced diabetes outcomes in patients with depression and diabetes mellitus
|
Wu, CS;Hsu, LY;Pan, YJ;Wang, SH |
| 國家衛生研究院 |
2021-07-14 |
A resistance mechanism in non-mcr colistin-resistant escherichia coli in Taiwan: R81H substitution in PmrA is an Independent factor contributing to colistin resistance
|
Wang, CH;Siu, LK;Chang, FY;Chiu, SK;Lin, JC |
| 淡江大學 |
2021-07-14 |
動態皮層-整合仿生設計與設計工作室學習
|
賴怡成 |
| 國立成功大學 |
2021-07-14 |
纖維加勁混凝土版抗炸性能補強之數值模擬研究
|
Syu, Hao-Jhu; 許皓筑 |
| 國立成功大學 |
2021-07-14 |
含苉七螺旋烴衍生物：合成與結構探討
|
林美辰; Lin, Mei-Chen |
| 國立成功大學 |
2021-07-14 |
多取代乙烯合菲和 Stone-Wales 缺陷片段：合成、結構分析和物性探討
|
Yu, Chia-Ling; 余家綾 |
| 國立成功大學 |
2021-07-14 |
苉類螺旋烴之合成研究探討、結構分析與性質探討
|
姜采欣; Jiang, Caxi-Xin |
| 國立成功大學 |
2021-07-14 |
應用地電阻於轉爐石掩埋探測：砂箱試驗
|
范庭瑜; Fan, Ting-Yu |
| 國立成功大學 |
2021-07-14 |
二茚并聯伸二苯衍生物之合成與結構分析
|
Su, Rou-Rong; 蘇柔蓉 |
| 國立成功大學 |
2021-07-14 |
在空間中具低對稱性之六環螺旋烴:合成研究､結構分析及其性質探究
|
李佩倫; Lee, Pei-Lun |
| 國立成功大學 |
2021-07-14 |
地震作用下加勁擋土牆動態反應與強度測量之關聯性
|
Lo, Yi-Yu; 羅翊瑜 |
| 國立成功大學 |
2021-07-14 |
竹纖維強化水泥砂漿機械性質:實驗及數值分析
|
潘哉勛; Hua, Zai-Shin |
| 國立成功大學 |
2021-07-14 |
具光子特性手性向列型液晶在感測及顯示元件上的應用研究
|
Hung, Yi-Hua; 洪逸樺 |
| 國立成功大學 |
2021-07-14 |
鈣離子缺乏誘導 FOXM1 類泛素化並聚集在細胞核內膜以影響細胞週期 G2/M 轉變
|
Chung, Ping-Jung; 鍾秉容 |
| 國立成功大學 |
2021-07-14 |
微型水平軸風機於不同入流條件下之數值模擬
|
Tsai, Shin-Ting; 蔡心婷 |
| 國立成功大學 |
2021-07-14 |
風向對於一大型風電場發電效率之影響探討
|
陳易煊; Chen, Yi-Hsuan |
| 國立成功大學 |
2021-07-14 |
AbpAB抑制腸道出血性大腸桿菌中志賀毒素的產生
|
Yang, Bing-Chang; 楊秉錩 |
